Skip to main content
Top
Published in: Journal of Endocrinological Investigation 9/2015

01-09-2015 | Original Article

The prevalence of benign breast diseases in patients with nodular goiter and Hashimoto’s thyroiditis

Authors: C. Anil, T. Guney, A. Gursoy

Published in: Journal of Endocrinological Investigation | Issue 9/2015

Login to get access

Abstract

Purpose

The evidence regarding association between thyroid disorders and benign and malignant breast diseases is increasing. The studies exploring the relationship between thyroid and breast diseases usually have focused on thyroid autoimmunity and functions in patients with breast pathologies. In this study, we aimed to reveal the frequency of benign breast conditions in patients with nodular thyroid disease (NTD) and Hashimoto’s thyroiditis (HT).

Methods

Seventy-one women with NTD, ninety-five women with HT and seventy-two healthy people as a control group were included in the study. Serum thyroid-stimulating hormone, free triiodothyronine, free thyroxine, and thyroid peroxidase autoantibody levels were measured, and thyroid and breast ultrasonography were performed by a single operator in order to determine thyroid and breast pathology.

Results

Benign breast diseases were detected in 54.9 % of patients with NTD, in 47.4 % of those with HT, and 29.2 % of control group in the study (p < 0.01 for nodular and Hashimoto groups versus control group). Simple cyst was found to be the most frequent pathology among benign breast diseases; fibrocystic changes, mixed lesions, benign solid mass, ductal ectasia, and complex cyst followed it. No significant relation was found regarding thyroid function and autoimmunity in patients diagnosed with benign breast disease (p > 0.05).

Conclusions

The results of our study support the association between benign breast diseases and thyroid diseases. An important implication of this finding may be demonstration of the necessity of scanning for potential breast pathology in women with nodular or autoimmune thyroid disease in clinical practice.
Literature
1.
go back to reference Salvatore D, Davies TF, Schlumberger MJ et al (2011) Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams Textbook of Endocrinology, 12th edn. Elsevier Saunders, Philadelphia, pp 327–478CrossRef Salvatore D, Davies TF, Schlumberger MJ et al (2011) Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams Textbook of Endocrinology, 12th edn. Elsevier Saunders, Philadelphia, pp 327–478CrossRef
2.
go back to reference Adamopoulos DA, Vassilaros S, Kapolla N et al (1986) Thyroid disease in patients with benign and malignant mastopathy. Cancer 57:125–128CrossRefPubMed Adamopoulos DA, Vassilaros S, Kapolla N et al (1986) Thyroid disease in patients with benign and malignant mastopathy. Cancer 57:125–128CrossRefPubMed
3.
go back to reference Giustarini E, Pinchera A, Fierabracci P et al (2006) Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 154:645–649CrossRefPubMed Giustarini E, Pinchera A, Fierabracci P et al (2006) Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 154:645–649CrossRefPubMed
4.
go back to reference Vassilopoulou-Sellin R, Palmer L, Taylor S et al (1999) Incidence of breast carcinoma in women with thyroid carcinoma. Cancer 85:696–705CrossRefPubMed Vassilopoulou-Sellin R, Palmer L, Taylor S et al (1999) Incidence of breast carcinoma in women with thyroid carcinoma. Cancer 85:696–705CrossRefPubMed
5.
go back to reference Saraiva PP, Figueiredo NB, Padovani CR et al (2005) Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 38:761–765CrossRefPubMed Saraiva PP, Figueiredo NB, Padovani CR et al (2005) Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 38:761–765CrossRefPubMed
6.
go back to reference Brunn J, Block U, Ruf G et al (1981) Volumetric Analysis of Thyroid Lobes by Realtime Ultrasound. Dtsch Med Wochenschr 106:1338–1340CrossRefPubMed Brunn J, Block U, Ruf G et al (1981) Volumetric Analysis of Thyroid Lobes by Realtime Ultrasound. Dtsch Med Wochenschr 106:1338–1340CrossRefPubMed
7.
go back to reference Mehta T (2003) Current uses of ultrasound in the evaluation of breast. Radiol Clin North Am 41:841–856CrossRefPubMed Mehta T (2003) Current uses of ultrasound in the evaluation of breast. Radiol Clin North Am 41:841–856CrossRefPubMed
8.
go back to reference Baskin B, Hadar O, Tashman S et al (2005) Sonographic diagnosis of breast cancer. In: Roses DF (ed) Breast Cancer, 2nd edn. Elsevier Churchill Livingstone, Philadelphia, pp 247–269CrossRef Baskin B, Hadar O, Tashman S et al (2005) Sonographic diagnosis of breast cancer. In: Roses DF (ed) Breast Cancer, 2nd edn. Elsevier Churchill Livingstone, Philadelphia, pp 247–269CrossRef
9.
go back to reference Giani C, Fierabracci P, Bonacci R et al (1996) Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 81:990–994PubMed Giani C, Fierabracci P, Bonacci R et al (1996) Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 81:990–994PubMed
10.
go back to reference Smyth PPA, Shering SG, Kilbane MT et al (1998) Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 83:2711–2716PubMed Smyth PPA, Shering SG, Kilbane MT et al (1998) Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 83:2711–2716PubMed
11.
12.
go back to reference Bhargav PRK, Mishra A, Agarwal G et al (2009) Prevalence of hypothyroidism in benign breast disorders and effect of thyroxine replacement on the clinical outcome. World J Surg 33:2087–2093CrossRefPubMed Bhargav PRK, Mishra A, Agarwal G et al (2009) Prevalence of hypothyroidism in benign breast disorders and effect of thyroxine replacement on the clinical outcome. World J Surg 33:2087–2093CrossRefPubMed
13.
go back to reference Prinzi N, Baldini E, Sorrenti S et al (2014) Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3921 patients. Breast Cancer Res Treat 144(3):683–688CrossRefPubMed Prinzi N, Baldini E, Sorrenti S et al (2014) Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3921 patients. Breast Cancer Res Treat 144(3):683–688CrossRefPubMed
14.
go back to reference Hardefeldt PJ, Eslick GD, Edirimanne S (2012) Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat 133(3):1169–1177CrossRefPubMed Hardefeldt PJ, Eslick GD, Edirimanne S (2012) Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat 133(3):1169–1177CrossRefPubMed
15.
go back to reference Tosovic A, Becker C, Bondeson AG et al (2012) Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer 131(9):2126–2133CrossRefPubMed Tosovic A, Becker C, Bondeson AG et al (2012) Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer 131(9):2126–2133CrossRefPubMed
16.
go back to reference Muller I, Pinchera A, Fiore E et al (2011) High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 34(5):349–352CrossRefPubMed Muller I, Pinchera A, Fiore E et al (2011) High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 34(5):349–352CrossRefPubMed
17.
go back to reference Nio Y, Iguchi C, Itakura M et al (2009) High incidence of synchronous or metachronous breast cancer in patients with malignant and benign thyroid tumor or tumor-like disorders. Anticancer Res 29(5):1607–1610PubMed Nio Y, Iguchi C, Itakura M et al (2009) High incidence of synchronous or metachronous breast cancer in patients with malignant and benign thyroid tumor or tumor-like disorders. Anticancer Res 29(5):1607–1610PubMed
18.
go back to reference Farahati J, Roggenbuck D, Gilman E et al (2012) Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer. Clin Chem Lab Med 50(4):709–714CrossRefPubMed Farahati J, Roggenbuck D, Gilman E et al (2012) Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer. Clin Chem Lab Med 50(4):709–714CrossRefPubMed
19.
go back to reference Ditsch N, Mayr D, Lenhard M et al (2012) Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma. Oncol Lett 4(4):665–671PubMedCentralPubMed Ditsch N, Mayr D, Lenhard M et al (2012) Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma. Oncol Lett 4(4):665–671PubMedCentralPubMed
20.
go back to reference Ditsch N, Toth B, Himsl I et al (2013) Thyroid hormone receptor (TR) alpha and TR beta expression in breast cancer. Histol Histopathol 28(2):227–237PubMed Ditsch N, Toth B, Himsl I et al (2013) Thyroid hormone receptor (TR) alpha and TR beta expression in breast cancer. Histol Histopathol 28(2):227–237PubMed
21.
go back to reference Govindaraj V, Yaduvanshi NS, Krishnamachar H et al (2012) Expression of thyroid-stimulating hormone receptor, octamer-binding transcription factor 4, and intracisternal A particle-promoted polypeptide in human breast cancer tissues. Horm Mol Biol Clin Investig 9(3):173–178PubMed Govindaraj V, Yaduvanshi NS, Krishnamachar H et al (2012) Expression of thyroid-stimulating hormone receptor, octamer-binding transcription factor 4, and intracisternal A particle-promoted polypeptide in human breast cancer tissues. Horm Mol Biol Clin Investig 9(3):173–178PubMed
Metadata
Title
The prevalence of benign breast diseases in patients with nodular goiter and Hashimoto’s thyroiditis
Authors
C. Anil
T. Guney
A. Gursoy
Publication date
01-09-2015
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 9/2015
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-015-0269-8

Other articles of this Issue 9/2015

Journal of Endocrinological Investigation 9/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.